Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-29 Purchase | 2023-10-03 4:00 pm | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 24,670 | $13.63 | $336,252 | 1,928,503 (Indirect) | View |
| 2023-09-26 Purchase | 2023-09-28 5:09 pm | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 30,000 | $13.15 | $394,500 | 1,903,833 (Indirect) | View |
| 2023-09-21 Purchase | 2023-09-25 4:15 pm | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat Chief Medical Officer | 4,000 | $13.2 | $52,800 | 4,000 (Direct) | View |
| 2023-09-19 Purchase | 2023-09-21 4:23 pm | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 30,000 | $13.2 | $396,000 | 1,873,833 (Indirect) | View |
| 2023-09-12 Purchase | 2023-09-13 9:17 pm | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 24,254 | $11.2 | $271,680 | 1,850,333 (Indirect) | View |
| 2023-02-07 Sale | 2023-02-09 4:30 pm | Magenta Therapeutics Inc. | MGTA | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 3,700,000 | $0.82595 | $3,056,000 | 3,058,204 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Other | 2024-04-01 6:21 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director | 58,857 | $0 | 2,880,551 (Indirect) | View |
| 2024-01-24 Option Award | 2024-01-26 4:51 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 80,000 | $0 | 80,000 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:46 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 110,000 | $0 | 110,000 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:43 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat CHIEF MEDICAL OFFICER | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:41 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CHIEF FINANCIAL OFFICER | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:36 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 275,000 | $0 | 275,000 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 7:04 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | MOULDER LEON O JR Director | 166,667 | $12 | 1,436,745 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-24 7:02 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 834,334 | $12 | 3,595,170 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-24 7:02 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 832,333 | $12 | 3,595,170 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-24 6:55 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Meng Lei Avidity Partners Management LP Gregory Michael David Avidity Partners Management (GP) LLC Witzke David Roy Director | 1,500,000 | $12 | 4,550,887 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-24 6:55 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Meng Lei Avidity Partners Management LP Gregory Michael David Avidity Partners Management (GP) LLC Witzke David Roy Director | 1,833,333 | $12 | 4,550,887 (Indirect) | View |
| 2023-09-11 Option Award | 2023-09-13 9:56 pm | N/A 2033-09-10 | Dianthus Therapeutics Inc. | DNTH | Meng Lei Avidity Partners Management LP Director | 6,500 | $0 | 6,500 (Indirect) | View |
Ownership | 2023-09-13 9:31 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Meng Lei Avidity Partners Management LP Director | 0 | $0 | 1,217,554 (Indirect) | View |
| 2023-09-11 Option Award | 2023-09-13 9:25 pm | N/A 2033-09-10 | Dianthus Therapeutics Inc. | DNTH | Violin Jonathan Director | 6,500 | $0 | 6,500 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 9:17 pm | N/A 2033-09-10 | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 6,500 | $0 | 1,850,333 (Indirect) | View |
| 2023-09-11 Option Award | 2023-09-13 9:17 pm | N/A 2033-09-10 | Dianthus Therapeutics Inc. | DNTH | Lawton Alison Frances Director | 6,500 | $0 | 6,500 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 9:16 pm | N/A 2033-09-10 | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 6,500 | $0 | 6,500 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 9:14 pm | N/A 2033-09-10 | Dianthus Therapeutics Inc. | DNTH | McGeorge Anne Director | 6,500 | $0 | 6,500 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 9:13 pm | N/A 2033-09-10 | Dianthus Therapeutics Inc. | DNTH | MOULDER LEON O JR Director | 6,500 | $0 | 6,500 (Direct) | View |
Ownership | 2023-09-13 8:55 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 1,819,579 (Indirect) | View |
Ownership | 2023-09-13 8:52 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 0 | $0 | 28,792 (Direct) | View |
Ownership | 2023-09-13 8:51 pm | N/A 2031-11-03 | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO and President | 0 | $0 | 508,663 (Direct) | View |
Ownership | 2023-09-13 8:50 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat Chief Medical Officer | 0 | $0 | 95,974 (Direct) | View |
Ownership | 2023-09-13 8:48 pm | N/A 2033-06-28 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M See Remarks | 0 | $0 | 88,240 (Direct) | View |
Ownership | 2023-09-13 8:47 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 0 | $0 | 95,974 (Direct) | View |
Ownership | 2023-09-13 8:46 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | MOULDER LEON O JR Director | 0 | $0 | 1,270,078 (Indirect) | View |
Ownership | 2023-09-13 8:45 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CHIEF FINANCIAL OFFICER | 0 | $0 | 124,766 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:26 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 3,000 | $0.94 | 19,897 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:23 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks | 3,000 | $0.94 | 17,264 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:23 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 3,000 | $0.94 | 19,762 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:23 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks | 3,000 | $0.94 | 944,954 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:19 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer | 3,000 | $0.94 | 20,264 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 08:19 am | N/A 2032-08-14 | Magenta Therapeutics Inc. | MGTA | VASCONCELLES MICHAEL Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:18 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:14 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 75,000 | $0 | 75,000 (Direct) | View |